Eric J. Ende - 01 Jan 2022 Form 3 Insider Report for NeuBase Therapeutics, Inc.

Role: Director
Signature: /s/ Dietrich Stephan, as attorney-in-fact for Eric Ende
Issuer symbol: N/A
Transactions as of: 01 Jan 2022
Net transactions value: $0
Form type: 3
Filing time: 05 Jan 2022, 15:04:31 UTC
Previous filing: 02 Nov 2021
Next filing: 31 May 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney